Skip to content
Nutrition & metabolismRandomised trial3 min read

Mediterranean diet beat low-fat diet for blood vessel function in 805 heart disease patients

MoveVitals Editorial Collective · Study published · Reading updated

Original paper:Mediterranean diet and endothelial function in patients with coronary heart disease: An analysis of the CORDIOPREV randomized controlled trial. · PLoS medicine · 2020 · Original paper ↗

Key takeaway

In 805 coronary heart disease patients randomized to a Mediterranean or low-fat diet, flow-mediated dilation (a test of blood vessel function) rose 3.83% on the Mediterranean diet versus 1.16% on low-fat, a difference of 2.63% (95% CI 1.89-3.40, p = 0.011). This was a secondary, exploratory analysis of a larger trial, so false positives are possible.

Study design

Randomised trial

Reading basis

Published abstract

Reading focus

Comparator & uncertainty

The research question

Damage to the inner lining of blood vessels (endothelial dysfunction) is a key step in atherosclerosis and predicts repeat heart events, but the best diet to protect it is unclear. The authors compared a Mediterranean diet with a low-fat diet on endothelial function in people with coronary heart disease, and explored the mechanisms behind any difference.

Who and how

Secondary analysis of CORDIOPREV, a prospective, randomized, single-blind, controlled trial in 1,002 coronary heart disease patients. 805 who completed endothelial testing at baseline were randomized to a Mediterranean diet (35% fat, 22% monounsaturated fat, <50% carbohydrates) or a low-fat diet (28% fat, 12% monounsaturated fat, >55% carbohydrates), with flow-mediated dilation of the brachial artery repeated after 1 year. Endothelial microparticles and progenitor cells were measured, and cell experiments plus epigenetic and protein analyses were done in 24 preselected patients.

What it found

The authors’ reported results. Read each estimate with its population and uncertainty.

  1. 1
    Flow-mediated dilation was higher on the Mediterranean diet (3.83%; 95% CI 2.91-4.23) than on the low-fat diet (1.16%; 95% CI 0.80-1.98), a difference of 2.63% (95% CI 1.89-3.40, p = 0.011), including in patients with severe endothelial dysfunction.
  2. 2
    Repair-related endothelial progenitor cells were higher (difference 1.64%; 95% CI 0.79-2.13, p = 0.028) and damage-related microparticles lower (difference -755 per μl; 95% CI -1,010 to -567, p = 0.015) on the Mediterranean diet.
  3. 3
    In the 24-patient cell experiments, the Mediterranean diet was associated with lower reactive oxygen species (p = 0.010), apoptosis (p = 0.013) and senescence (p = 0.031), and higher cell proliferation (p = 0.011) and angiogenesis (p = 0.022).
  4. 4
    Each diet was associated with distinct epigenetic and protein changes related to endothelial dysfunction.

Limits & uncertainty

  1. 1
    The authors state this is a substudy with exploratory analyses, so false-positive findings are possible.
  2. 2
    The mechanism experiments used only 24 preselected patients, and the abstract does not say how they were chosen beyond that.
  3. 3
    Vessel function was a surrogate marker measured at 1 year; it does not show fewer heart attacks, which is the main trial outcome and is not reported here. This reading is based on the abstract only.

What to take from it

The results suggest a Mediterranean-style diet may improve how well blood vessels respond in people with coronary heart disease, compared with a low-fat diet. It does not show fewer heart events, and anyone with heart disease should discuss diet changes with their cardiologist.

Reading your own data

Flow-mediated dilation is a clinic test, not something a wearable measures. Related data you can log include blood pressure from a home cuff, weight and food logs, tracked consistently over months and compared with your own earlier readings.

How to read this evidence

Randomisation can support causal inference, but check allocation, blinding, missing outcomes, follow-up and the actual comparator. A trial label alone does not establish high certainty.

Authors’ structured abstract English

The attributed English abstract is reproduced under the recorded open licence. It is source material, not a MoveVitals interpretation. The prepared analysis above separates the authors’ findings from our interpretation.

Background

Endothelial dysfunction is a crucial step in atherosclerosis development, and its severity is determinant for the risk of cardiovascular recurrence. Diet may be an effective strategy to protect the endothelium, although there is no consensus about the best dietary model. The CORonary Diet Intervention with Olive oil and cardiovascular PREVention (CORDIOPREV) study is an ongoing prospective, randomized, single-blind, controlled trial in 1,002 coronary heart disease (CHD) patients, whose primary objective is to compare the effect of 2 healthy dietary patterns (low-fat versus Mediterranean diet) on the incidence of cardiovascular events. Here, we report the results of one secondary outcome of the CORDIOPREV study: to evaluate the effect of these diets on endothelial function, assessed by flow-mediated dilation (FMD) of the brachial artery.

Methods and findings

From the total participants taking part in the CORDIOPREV study, 805 completed endothelial function study at baseline and were randomized to follow a Mediterranean diet (35% fat, 22% monounsaturated fatty acids [MUFAs], and <50% carbohydrates) or a low-fat diet (28% fat, 12% MUFAs, and >55% carbohydrates), with endothelial function measurement repeated after 1 year. As secondary objectives and to explore different underlying mechanisms in the modulation of endothelial function, we quantified endothelial microparticles (EMPs) and endothelial progenitor cells (EPCs) and evaluated, in 24 preselected patients, in vitro cellular processes related to endothelial damage (reactive oxygen species, apoptosis, and senescence) and endothelial repair (cell proliferation and angiogenesis), as well as other modulators (micro-RNAs [miRNAs] and proteins). Patients who followed the Mediterranean diet had higher FMD (3.83%; 95% confidence interval [CI]: 2.91-4.23) compared with those in the low-fat diet (1.16%; 95% CI: 0.80 to 1.98) with a difference between diets of 2.63% (95% CI: 1.89-3.40, p = 0.011), even in those patients with severe endothelial dysfunction. We observed higher EPC levels (group difference: 1.64%; 95% CI: 0.79-2.13, p = 0.028) and lower EMPs (group difference: -755 EMPs/μl; 95% CI: -1,010 to -567, p = 0.015) after the Mediterranean diet compared with the low-fat diet in all patients. We also observed lower intracellular reactive oxygen species (ROS) production (group difference: 11.1; 95% CI: 2.5 to 19.6, p = 0.010), cellular apoptosis (group difference: -20.2; 95% CI: -26.7 to -5.11, p = 0.013) and senescence (18.0; 95% CI: 3.57 to 25.1, p = 0.031), and higher cellular proliferation (group difference: 11.3; 95% CI: 4.51 to 13.5, p = 0.011) and angiogenesis (total master segments length, group difference: 549; 95% CI: 110 to 670, p = 0.022) after the Mediterranean diet than the low-fat diet. Each dietary intervention was associated with distinct changes in the epigenetic and proteomic factors that modulate biological process associated with endothelial dysfunction. The evaluation of endothelial function is a substudy of the CORDIOPREV study. As in any substudy, these results should be treated with caution, such as the potential for false positives because of the exploratory nature of the analyses.

Conclusions

Our results suggest that the Mediterranean diet better modulates endothelial function compared with a low-fat diet and is associated with a better balance of vascular homeostasis in CHD patients, even in those with severe endothelial dysfunction.

Clinical trial registration

URL, http://www.cordioprev.es/index.php/en. clinicaltrials.gov number NCT00924937.

Sources & attribution

Mediterranean diet and endothelial function in patients with coronary heart disease: An analysis of the CORDIOPREV randomized controlled trial.

Yubero-Serrano EM, Fernandez-Gandara C, Garcia-Rios A, Rangel-Zuñiga OA, Gutierrez-Mariscal FM, Torres-Peña JD, Marin C, Lopez-Moreno J, Castaño JP, Delgado-Lista J, Ordovas JM, Perez-Martinez P, Lopez-Miranda J.

PLoS medicine · 2020-09-09

DOI: 10.1371/journal.pmed.1003282 ↗PubMed · 32903262 ↗Europe PMC · Recorded licence: cc by ↗

Abstract © the original authors, reproduced under the recorded open licence. Translations support reading; use the English record to check terminology and numerical results. Our methodological interpretation is separate from the authors’ conclusions.

MoveVitals editorial interpretation · educational content · no individual clinical review recorded

Sources checked 2026-11-01

Practical guides

Read in context

·Trial meta-analysis

Early time-restricted eating linked to more weight loss and lower insulin than late eating

Pooling 41 randomised trials (2287 participants, median intervention 8 weeks), time-restricted eating was associated with 2.15 kg lower body weight than usual diets (95% CI -2.56 to -1.74), and eating early beat eating late by 1.15 kg (95% CI -1.86 to -0.45). Most trials were short, only 6 study arms tested early eating, and the outcomes were body and blood measures, not heart attacks or deaths.

BMJ Medicine

In-depth explainersRead study →
·Randomised trial

An 8 a.m. to 4 p.m. eating window added to calorie cutting gave no clear extra weight loss

Among 139 patients with obesity on a calorie-restricted diet, adding an eating window of 8:00 a.m. to 4:00 p.m. led to a mean 12-month weight change of -8.0 kg, versus -6.3 kg with calorie restriction alone. The net difference of -1.8 kg (95% CI -4.0 to 0.4; P = 0.11) was not statistically significant, and the interval cannot rule out either a real benefit or none.

The New England Journal of Medicine

In-depth explainersRead study →
·Randomised trial

In a 20-person ward trial, an ultra-processed menu led to more eating and weight gain

In 20 adults living in a hospital research unit for 28 days, an ultra-processed menu led them to eat 508 kcal/day more (± 106 SE, P = 0.0001) and gain 0.9 kg, while a menu of unprocessed foods led to a 0.9 kg loss, each over 2 weeks and with eating left to appetite. The study was small, short and fully provisioned, so it cannot show what happens in daily life or which feature of the foods drove the extra eating.

Cell Metabolism

In-depth explainersRead study →
·Randomised trial

Mediterranean diet with olive oil or nuts linked to fewer heart events (corrected trial)

Among 7447 Spanish adults aged 55 to 80 at high cardiovascular risk, those assigned to a Mediterranean diet with extra-virgin olive oil (HR 0.69, 95% CI 0.53 to 0.91) or with nuts (HR 0.72, 0.54 to 0.95) had fewer major cardiovascular events than those told to cut dietary fat. The trial had randomisation errors, which is why the 2013 report was withdrawn and the estimates recalculated, so treat this as strong but imperfect evidence.

The New England Journal of Medicine

In-depth explainersRead study →
Nutrition & metabolism →